{"product_id":"global-tuberculosis-tb-detection-market-growth-status-and-outlook-2023-2029","title":"Global Tuberculosis (TB) Detection Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Tuberculosis (TB) Detection Market Growth (Status and Outlook) 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eTuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.\u003cbr\u003e\nTuberculosis (TB) is a chronic and slow - onset infectious disease in young people.The incubation period is 4 to 8 weeks.Of these, 80% occur in the lungs, and other areas (cervical lymph, meninges, peritoneum, intestine, skin, bone) may also be secondary to infection.Transmission of respiratory tract from person to person is the main mode of transmission.Infection source is the person that contacts the tuberculosis that discharges bacterium.With the spread of environmental pollution and AIDS, the incidence of TB is becoming more and more intense.In addition to a few cases of rapid onset, clinical more chronic process.There are often low fever, fatigue and other systemic symptoms and respiratory symptoms such as cough, hemoptysis.\u003cbr\u003e\nLPI (LP Information)' newest research report, the “Tuberculosis (TB) Detection Industry Forecast” looks at past sales and reviews total world Tuberculosis (TB) Detection sales in 2022, providing a comprehensive analysis by region and market sector of projected Tuberculosis (TB) Detection sales for 2023 through 2029. With Tuberculosis (TB) Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis (TB) Detection industry.\u003cbr\u003e\nThis Insight Report provides a comprehensive analysis of the global Tuberculosis (TB) Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis (TB) Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tuberculosis (TB) Detection market.\u003cbr\u003e\nThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis (TB) Detection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis (TB) Detection.\u003cbr\u003e\nThe global Tuberculosis (TB) Detection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.\u003cbr\u003e\nIn Southeast Asia, Tuberculosis (TB) Detection key players include Danaher, Roche, Thermal Fisher, Abbott, etc.\u003cbr\u003e\nIndonesia is the largest market, with a share over 20%, followed by Philippines, and Myanmar, both have a share about 30 percent. \u003cbr\u003e\nIn terms of product, Bacterial Culture Test is the largest segment, with a share about 50%. And in terms of application, the largest application is Hospital, followed by Clinic, Research Institution, etc.\u003cbr\u003e\nThis report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis (TB) Detection market by product type, application, key players and key regions and countries.\u003cbr\u003e\nMarket Segmentation:\u003cbr\u003e\nSegmentation by type\u003cbr\u003e\n Bacterial Culture Test\u003cbr\u003e\n Tuberculin Test\u003cbr\u003e\n Rapid Molecular Diagnosis\u003cbr\u003e\n Other\u003cbr\u003e\nSegmentation by application\u003cbr\u003e\n Hospital\u003cbr\u003e\n Clinic\u003cbr\u003e\n Research Institution\u003cbr\u003e\n Other\u003cbr\u003e\nThis report also splits the market by region:\u003cbr\u003e\n Americas\u003cbr\u003e\n United States\u003cbr\u003e\n Canada\u003cbr\u003e\n Mexico\u003cbr\u003e\n Brazil\u003cbr\u003e\n APAC\u003cbr\u003e\n China\u003cbr\u003e\n Japan\u003cbr\u003e\n Korea\u003cbr\u003e\n Southeast Asia\u003cbr\u003e\n India\u003cbr\u003e\n Australia\u003cbr\u003e\n Europe\u003cbr\u003e\n Germany\u003cbr\u003e\n France\u003cbr\u003e\n UK\u003cbr\u003e\n Italy\u003cbr\u003e\n Russia\u003cbr\u003e\n Middle East \u0026amp; Africa\u003cbr\u003e\n Egypt\u003cbr\u003e\n South Africa\u003cbr\u003e\n Israel\u003cbr\u003e\n Turkey\u003cbr\u003e\n GCC Countries\u003cbr\u003e\nThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\n Danaher\u003cbr\u003e\n Roche\u003cbr\u003e\n Thermal Fisher\u003cbr\u003e\n Abbott\u003cbr\u003e\n Oxford Immunotec International\u003cbr\u003e\n Qiagen\u003cbr\u003e\n Hologic\u003cbr\u003e\n Hain Lifescience\u003cbr\u003e\n Epistem\u003cbr\u003e\n Creative Diagnostics\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 101 Pages \/ MCW16234605","offer_id":47650979676466,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-tuberculosis-tb-detection-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}